Impact of Prior Antiplatelet Therapy on Risk of Embolism in Infective Endocarditis
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Embolism is a dreaded complication of infective endocarditis (IE). Currently, antimicrobial therapy is the only medical intervention proven to decrease the risk of embolism associated with IE. We hypothesized that, because platelet aggregation is operative in the pathogenesis of vegetation formation, embolism associated with IE should occur less frequently among patients who have received prior, continuous daily antiplatelet therapy for noninfectious reasons. METHODS: We studied a retrospective cohort of adult patients with a diagnosis of IE who presented to the Mayo Clinic (Rochester, MN) during 1980-1998. The cohort was divided into 2 groups on the basis of whether they had received continuous daily antiplatelet therapy for at least 6 months prior to the time of hospitalization for IE. Antiplatelet therapy included aspirin, dipyridamole, clopidogrel, ticlopidine, or any of combination of these agents. The primary end point was a symptomatic embolic event that occurred prior to or during hospitalization. Multivariable logistic regression was used to assess the impact of continuous daily antiplatelet therapy on risk of symptomatic emboli associated with IE. RESULTS: One hundred forty-seven (24.5%) of 600 patients experienced a symptomatic embolic event; the most common embolic manifestation was stroke (in 48.2% of patients). Embolic events occurred significantly less often among those who had received prior, continuous daily antiplatelet therapy (12.0% of patients who had received therapy vs. 27.8% patients who had not receive therapy; P<.001). After adjustment for several covariates known to influence both risk of embolism and propensity for antiplatelet use, the adjusted odds ratio for a symptomatic embolic event was 0.36 (95% confidence interval, 0.19-0.68; P=.002) for patients receiving continuous daily antiplatelet therapy. CONCLUSIONS: The risk of symptomatic emboli associated with IE was reduced in patients who received continuous daily antiplatelet therapy before onset of IE.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retrospective, observational studies 290-296 have examined the impact, if any, of long-term antiplatelet therapy before the onset of IE on infection-related outcomes.Findings from these investigations have been mixed in terms of IE-related outcomes.”
Citations
Cites
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027
Bulletin of the World Health Organization
C., N. H. (1955) · The British Journal of Sociology · doi:10.2307/587237 · Cited by 3,601
Estimating Causal Effects from Large Data Sets Using Propensity Scores
Rubin, D. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00064 · Cited by 2,877
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Self-citationExperience from a multicentre stroke register: a preliminary report.
Hatano, S. (1976) · Europe PMC (PubMed Central) · Cited by 1,526
Patrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
(1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251801 · Cited by 759
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
Patrono, C., Coller, B., FitzGerald, G. A., Hirsh, J., & Roth, G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.234s · Cited by 671
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Self-citationNishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,905
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000932 · Cited by 2,449
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.018 · Cited by 1,982
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.035 · Cited by 1,075
2014 AHA/ACC guideline for the management of patients with valvular heart disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.05.014 · Cited by 989
García-Cabrera, E., Fernández-Hidalgo, N., Almirante, B., Ivanova-Georgieva, R., Noureddine, M., Plata, A., Lomas, J. M., Gálvez-Acebal, J., Hidalgo-Tenorio, C., Ruíz-Morales, J., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000813 · Cited by 546
Hoen, B., & Duval, X. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1206782 · Cited by 467
Infective Endocarditis Epidemiology Over Five Decades: A Systematic Review
Slipczuk, L., Codolosa, J. N., Davila, C. D., Romero-Corral, A., Yun, J., Pressman, G. S., & Figueredo, V. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082665 · Cited by 453
Pettersson, G. B., Coselli, J. S., Pettersson, G. B., Coselli, J. S., Hussain, S. T., Griffin, B., Blackstone, E. H., Gordon, S. M., LeMaire, S. A., & Woc-Colburn, L. E. (2017) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.09.093 · Cited by 410
Snygg‐Martin, U., Gustafsson, L., Rosengren, L., Alsiö, Å., Ackerholm, P., Andersson, R., & Olaison, L. (2008) · Clinical Infectious Diseases · doi:10.1086/588663 · Cited by 320
“Compared with patients described in the National Swedish Endocarditis Registry during the same period of time, the patients in this prospective radiological and neurochemical study are well matched and reflect an elderly cohort with a high rate of cardiovascular comorbidity, similar to patients in other modern infecti…”
ResultDurante-Mangoni, E. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.19.2095 · Cited by 291
2020 ACC/AHA guideline for the management of patients with valvular heart disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.002 · Cited by 279
Bin Abdulhak, A. A., Baddour, L. M., Erwin, P. J., Hoen, B., Chu, V. H., Mensah, G. A., & Tleyjeh, I. M. (2014) · Global Heart · doi:10.1016/j.gheart.2014.01.002 · Cited by 233
Self-citationInfective Endocarditis: A Contemporary Review
Hubers, S. A., DeSimone, D. C., Gersh, B. J., & Anavekar, N. S. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.12.008 · Cited by 200
Self-citationPregnancy and Postpartum Infective Endocarditis
Kebed, K. Y., Bishu, K. G., Adham, R. I. A., Baddour, L. M., Connolly, H. M., Sohail, M. R., Steckelberg, J. M., Wilson, W. R., Murad, M. H., & Anavekar, N. S. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.04.024 · Cited by 104
Self-citationEffect of Long-Term Aspirin Use on Embolic Events in Infective Endocarditis
Chan, K.-L., Tam, J., Dumesnil, J. G., Cujec, B., Sanfilippo, A. J., Jue, J., Turek, M., Robinson, T., & Williams, K. (2008) · Clinical Infectious Diseases · doi:10.1086/524021 · Cited by 95
Infective Endocarditis: A Focus on Oral Microbiota
Giudice, C. D., Vaia, E., Liccardo, D., Marzano, F., Valletta, A., Spagnuolo, G., Ferrara, N., Rengo, C., Cannavò, A., & Rengo, G. (2021) · Microorganisms · doi:10.3390/microorganisms9061218 · Cited by 90
Current Challenges in the Management of Infective Endocarditis
Cuervo, G., Escrihuela-Vidal, F., Gudiol, C., & Carratalà, J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.641243 · Cited by 88
The role of human extracellular matrix proteins in defining Staphylococcus aureus biofilm infections
Bhattacharya, M., & Horswill, A. R. (2024) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuae002 · Cited by 83
Management of neurological complications of infective endocarditis in ICU patients
Sonneville, R., Mourvillier, B., Bouadma, L., & Wolff, M. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-10 · Cited by 82
Eisen, D. P. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2570-8 · Cited by 79
An Altered Immunity Hypothesis for the Development of Symptomatic Bacterial Vaginosis
Witkin, S. S., Linhares, I. M., Giraldo, P. C., & Ledger, W. J. (2007) · Clinical Infectious Diseases · doi:10.1086/511045 · Cited by 72
Infectious endocarditis and infection of intracardiac devices in adults. Clinical guidelines 2021
Демин, А. А., Kobalava, Z. D., Skopin, I. I., Tyurin, P. V., Boytsov, S. A., Golukhova, E. Z., Гордеев, М. Л., Gudymovich, V. D., Demchenko, E. A., Дробышева, В. П., et al. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2022-5233 · Cited by 69
Veloso, T. R., Que, Y., Chaouch, A., Giddey, M., Vouillamoz, J., Rousson, V., Moreillon, P., & Entenza, J. M. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu426 · Cited by 69
Yang, A., Tan, C. E., Daneman, N., Hansen, M. S., Habib, G., Salaün, E., Lavoûte, C., Hubert, S., & Adhikari, N. K. J. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.08.010 · Cited by 66
Cheung, G., Vejlstrup, N. G., Ihlemann, N., Arnous, S., Franzen, O. W., Bundgaard, H., & Søndergaard, L. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.10.016 · Cited by 63
Okazaki, S., Yoshioka, D., Sakaguchi, M., Sawa, Y., Mochizuki, H., & Kitagawa, K. (2013) · Cerebrovascular Diseases · doi:10.1159/000346101 · Cited by 57
Ferro, J. M., & Fonseca, A. C. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4086-3.00007-2 · Cited by 57
Neurological complications of infective endocarditis: New breakthroughs in diagnosis and management
Novy, E., Sonneville, R., Mazighi, M., Klein, I. F., Mariotte, É., Mourvillier, B., Bouadma, L., & Wolff, M. (2013) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2013.09.010 · Cited by 56
Tunjungputri, R. N., van der Heijden, W., Urbanus, R. T., de Groot, P. G., van der Ven, A. J. A. M., & de Mast, Q. (2016) · Platelets · doi:10.1080/09537104.2016.1252837 · Cited by 55
Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J., Zotti, F. D., Dulgheru, R., Khoury, G. A. E., Erba, P. A., Iung, B., et al. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.11.015 · Cited by 54
Mean platelet volume predicts embolic complications and prognosis in infective endocarditis
Günebakmaz, Ö., Kaya, M. G., Kaya, E., Ardıç, İ., Yarlıoğlueş, M., Doğdu, O., Kalay, N., Akpek, M., Şarlı, B., & Özdoğru, İ. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.05.019 · Cited by 52
Pediatric Endocarditis and Stroke: A Single-Center Retrospective Review of Seven Cases
Venkatesan, C., & Wainwright, M. S. (2008) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.12.009 · Cited by 49
Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., Antunes, M. J., Thilén, U. J., Lekakis, J. P., et al. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)73131-8 · Cited by 43
Rasmussen, R. V., Snygg-Martin, U., Olaison, L., Buchholtz, K., Larsen, C. T., Hassager, C., & Bruun, N. E. (2009) · Cardiology · doi:10.1159/000235579 · Cited by 41
Chronic antiplatelet therapy and mortality among patients with infective endocarditis
Pepin, J., Tremblay, V., Bechard, D., Rodier, F., Walker, C., Dufresne, D., Lafontaine, A., Li, N., Lacroix, C., & Lanthier, L. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02665.x · Cited by 42
“According to univariate analysis, mortality did not differ between groups; as in our study, those on chronic antiplatelet therapy were older and had a higher Charlson score, but no multivariate analysis of risk factors for mortality was reported [18].”
InfluentialEisen, D. P., Corey, G. R., McBryde, E. S., Fowler, V. G., Miro, J. M., Cabell, C. H., Street, A. C., Paiva, M. G., Ionac, A., Tan, R.-S., et al. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.03.006 · Cited by 40
Martin, D. R., Witten, J. C., Tan, C. D., Rodríguez, E. R., Blackstone, E. H., Pettersson, G., Seifert, D. E., Willard, B. B., & Apte, S. (2020) · JCI Insight · doi:10.1172/jci.insight.135317 · Cited by 36
Aspirin and Infection: A Narrative Review
Bella, S. D., Luzzati, R., Principe, L., Zerbato, V., Meroni, E., Giuffrè, M., Crocè, L. S., Merlo, M., Perotto, M., Dolso, E., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10020263 · Cited by 36
Aspirin Effect on Staphylococcus aureus—Platelet Interactions During Infectious Endocarditis
Hannachi, N., Habib, G., & Camoin‐Jau, L. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00217 · Cited by 36
Surgical treatment for infective endocarditis in elderly patients
Ramírez‐Duque, N., García-Cabrera, E., Georgieva, R. I., Noureddine, M., Lomas, J. M., Hidalgo-Tenorio, C., Plata, A., Gálvez-Acebal, J., Ruiz‐Morales, J., Lima, J. D. L. T., et al. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.05.021 · Cited by 35
Effectiveness of Thrombolytic Therapy in Acute Embolic Stroke due to Infective Endocarditis
Sontineni, S. P., Mooss, A. N., Andukuri, V. G., Schima, S. M., & Esterbrooks, D. J. (2009) · Stroke Research and Treatment · doi:10.4061/2010/841797 · Cited by 33
Modifiers of Symptomatic Embolic Risk in Infective Endocarditis
Anavekar, N. S., Schultz, J. C., De Sa, D. D. C., Thomas, J. M., Lahr, B. D., Tleyjeh, I. M., Steckelberg, J. M., Wilson, W. R., & Baddour, L. M. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0111 · Cited by 31
“Results of these studies have suggested that, although antiplatelet therapy initiated after the diagnosis of IE is not helpful and potentially harmful due to bleeding risk,(6,7) antiplatelet therapy administered in the long term before the onset of valvular infection may reduce symptomatic embolism in IE.(5) In additi…”
BackgroundResultSelf-citationNative Infective Endocarditis: A State-of-the-Art-Review
Nappi, F. (2024) · Microorganisms · doi:10.3390/microorganisms12071481 · Cited by 31
Anti-thrombotic therapy in infective endocarditis
Vanassche, T., Peetermans, W. E., Herregods, M., Herijgers, P., & Verhamme, P. B. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.100 · Cited by 30
Veloso, T. R., Oechslin, F., Que, Y., Moreillon, P., Entenza, J. M., & Mancini, S. (2015) · Pathogens and Disease · doi:10.1093/femspd/ftv060 · Cited by 29
Current trends in the management of cardiac implantable electronic device (CIED) infections
Durante‐Mangoni, E., Mattucci, I., Agrusta, F., Tripodi, M., & Utili, R. (2012) · Internal and Emergency Medicine · doi:10.1007/s11739-012-0797-6 · Cited by 27
Antiplatelet Agents Have a Distinct Efficacy on Platelet Aggregation Induced by Infectious Bacteria
Hannachi, N., Ogé-Ganaye, E., Baudoin, J., Fontanini, A., Bernot, D., Habib, G., & Camoin‐Jau, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00863 · Cited by 27
Kan, P. T. M., Webb, S. W., Siddiqui, A. H., & Levy, E. I. (2011) · World Neurosurgery · doi:10.1016/j.wneu.2011.05.059 · Cited by 26
Snygg-Martin, U., Rasmussen, R. V., Hassager, C., Bruun, N. E., Andersson, R., & Olaison, L. (2011) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2011.603742 · Cited by 25
“The results of prospective human studies [10 – 12] and recently published retrospective analyses are confl icting [4,13,14].”
ResultThe Role of Platelets in Infective Endocarditis
Braï, M. A., Hannachi, N., Gueddari, N. E., Baudoin, J., Dahmani, A., Lépidi, H., Habib, G., & Camoin‐Jau, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087540 · Cited by 24
Yeaman, M. R., & Bayer, A. S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387837-3.00037-7 · Cited by 24
Outcome and prognostic factors in infective endocarditis in dogs: 113 cases (2005-2020)
Reagan, K. L., Visser, L. C., Epstein, S., Stern, J. A., & Johnson, L. R. (2022) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16380 · Cited by 23
Papadimitriou‐Olivgeris, M., Guery, B. P., Ianculescu, N., Auberson, D., Tozzi, P., Kirsch, M. E. W., & Monney, P. A. (2023) · Infection · doi:10.1007/s15010-023-02066-z · Cited by 23
Neurological Complications and Clinical Outcomes of Infective Endocarditis
Das, A. S., McKeown, M. E., Jordan, S. A., Li, K., Regenhardt, R. W., & Feske, S. K. (2022) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2022.106626 · Cited by 22
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Cited by 22
Houard, V., Porte, L., Delon, C., Carrié, D., Delobel, P., Galinier, M., Lairez, O., & Badie, Y. L. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.005 · Cited by 22
Role of Vegetation-Associated Protease Activity in Valve Destruction in Human Infective Endocarditis
Al-Salih, G., Al‐Attar, N., Delbosc, S., Louedec, L., Corvazier, E., Loyau, S., Michel, J., Pidard, D., Duval, X., & Meilhac, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045695 · Cited by 22
Habib, A., Irfan, M., Baddour, L. M., Le, K. Y., Anavekar, N. S., Lohse, C. M., Friedman, P. A., Hayes, D. L., Wilson, W. R., Steckelberg, J. M., et al. (2012) · EP Europace · doi:10.1093/europace/eus292 · Cited by 22
Self-citationHannachi, N., Lépidi, H., Fontanini, A., Takakura, T., Khalil, J. B., Gouriet, F., Habib, G., Raoult, D., Camoin‐Jau, L., & Baudoin, J. (2020) · Cells · doi:10.3390/cells9081899 · Cited by 21
Fungal pericarditis and endocarditis secondary to porcupine quill migration in a dog
Costa, A. P., Lahmers, S. M., Barry, S. L., Stanton, J. B., & Stern, J. A. (2014) · Journal of Veterinary Cardiology · doi:10.1016/j.jvc.2014.09.003 · Cited by 21
Aspirin or Ticagrelor in Staphylococcus aureus Infective Endocarditis: Where Do We Stand?
Leeten, K., Jacques, N., Lancellotti, P., & Oury, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716302 · Cited by 20
Bacterial Endocarditis and Cerebrovascular Disease
Silver, B., Behrouz, R., & Silliman, S. L. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0705-y · Cited by 20
Antithrombotic Therapy in Patients With Infective Endocarditis
Caldonazo, T. M. M., Musleh, R., Moschovas, A., Kirov, H., Franz, M., Hæusler, K. G., Faerber, G., Doenst, T., Günther, A., & Diab, M. (2023) · JACC Advances · doi:10.1016/j.jacadv.2023.100768 · Cited by 17
The distinct effects of aspirin on platelet aggregation induced by infectious bacteria
Hannachi, N., Baudoin, J., Prasanth, A., Habib, G., & Camoin‐Jau, L. (2019) · Platelets · doi:10.1080/09537104.2019.1704717 · Cited by 17
Wang, A., & Cabell, C. H. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-411-7_21 · Cited by 16
Platelet reactivity in diabetic patients with invasive Klebsiella pneumoniae liver abscess syndrome
Lee, C., Chuah, S., Tai, W., & Chen, I. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s174913 · Cited by 16
Complications neurologiques des endocardites infectieuses
Sonneville, R., Klein, I. F., Bouadma, L., Mourvillier, B., Regnier, B., & Wolff, M. (2009) · Réanimation · doi:10.1016/j.reaurg.2009.06.010 · Cited by 16
Increased mean platelet volume in patients with infective endocarditis and embolic events
İleri, M., Kanat, S., Orhan, G., Bayır, P. T., Gürsoy, H. T., Şahin, D., Çiçek, G., ELALMIŞ, Ö. U., & Güray, Ü. (2014) · Cardiology Journal · doi:10.5603/cj.a2014.0021 · Cited by 16
AlBassri, T., Sheikho, M., Chaikhouni, F., Alhabshan, F., & Kabbani, M. S. (2021) · International Journal of Pediatrics and Adolescent Medicine · doi:10.1016/j.ijpam.2021.02.003 · Cited by 14
Maheshwari, R., Wardman, D. L., Cordato, D. J., & Bhaskar, S. M. M. (2021) · Immuno · doi:10.3390/immuno1040023 · Cited by 13
Eisen, D. P., & McBryde, E. S. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv131 · Cited by 13
Infective Endocarditis and Antithrombotic Therapy
Morelli, C., Rocca, B., & Gigante, B. (2024) · Cardiology · doi:10.1159/000538549 · Cited by 12
Alegria, S., Marques, A., Cruz, I. R., Broa, A. L., Pereira, A. R., João, I., Simões, O., & Pereira, H. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20190586 · Cited by 12
The Role of Platelets in Antimicrobial Host Defense
Yeaman, M. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00029-1 · Cited by 12
Staphylococcus aureus increases platelet reactivity in patients with infective endocarditis
Polzin, A., Dannenberg, L., M’Pembele, R., Mourikis, P., Naguib, D., Zako, S., Helten, C., Petzold, T., Levkau, B., Hohlfeld, T., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16681-7 · Cited by 11
Haliga, R. E., Șorodoc, V., Morarasu, B. C., Coman, A. E., Ceasovschih, A., Sîrbu, O., Lionte, C., Bologa, C., Stoica, A. M., Constantin, M., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13020300 · Cited by 10
Inayat, F., Virk, H. H., Farooq, S., Ghani, A. R., Mirrani, G., & Athar, M. W. (2016) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.185040 · Cited by 10
Bacterial and fungal infections in persons who inject drugs
Masters, J., Goodman‐Meza, D., Russell, D. M., Marks, L. R., McCreary, E. K., Jacka, B. P., Seear, K., Davis, J. S., Matthews, G. V., Martinello, M., et al. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00162-23 · Cited by 9
Learning From Controversy: Contemporary Surgical Management of Aortic Valve Endocarditis
Nappi, F., Singh, S. S. A., & Timofeeva, I. (2020) · Clinical Medicine Insights Cardiology · doi:10.1177/1179546820960729 · Cited by 9
Bacterial interactions with platelets: defining key themes
Alfar, H. R., & Whiteheart, S. W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1610289 · Cited by 8
The long and short of vegetations in infective endocarditis
Vikram, H. R. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.4.529 · Cited by 8
Impact of Prior Antiplatelet Therapy on Risk of Embolism in Infective Endocarditis
Cheitlin, M. D. (2008) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)01003-4 · Cited by 7
Aspirin Use in Infective Endocarditis
Eisen, D. P., & Bayer, A. S. (2008) · Clinical Infectious Diseases · doi:10.1086/587181 · Cited by 7
Deciphering the Complex Relationships Between the Hemostasis System and Infective Endocarditis
Wahab, M. A., Khan, A. U., Mercadante, S., Cafarella, I., Bertolino, L., & Durante‐Mangoni, E. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113965 · Cited by 6
Lee, T. T. L., Chan, S. C. L., Chou, O. H. I., Lee, S., Chan, J. S. K., Liu, T., Chang, C., Wong, W. T., Lip, G. Y. H., Cheung, B. M. Y., et al. (2023) · Thrombosis Research · doi:10.1016/j.thromres.2023.11.009 · Cited by 6
Embolic ST-elevation Myocardial Infarction from Candida Endocarditis
Ghazzal, A., Gill, G. S., Radwan, S. S., & Barnett, C. F. (2020) · Cureus · doi:10.7759/cureus.7833 · Cited by 6
Salehian, O., & Chan, K. (2006) · Springer eBooks · doi:10.1007/978-1-84628-453-3_13 · Cited by 6
Coagulation and infective endocarditis: sooner or later
Santilli, F., Simeone, P., & Davì, G. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1258-9 · Cited by 6
Borrelli, N., Avesani, M., Oreto, L., Leonardi, B., Gaudieri, G., Bianco, F., Bucciarelli, V., Sabatino, J., Russo, M. G., Sarubbi, B., et al. (2025) · Pediatric Cardiology · doi:10.1007/s00246-025-03984-5 · Cited by 5
Harrak, H., Normand, I., Grinker, R., Elftouh, N., Laurin, L., & Lafrance, J. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0112-7 · Cited by 5
Delahaye, F. (2012) · EMC - Cardiologie · doi:10.1016/s1166-4568(12)57330-4 · Cited by 5
Adding Fuel to the Fire: Infective Endocarditis and the Challenge of Cerebrovascular Complications
Sharma, M., & Davis, A. P. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01856-z · Cited by 5
Yaméogo, N. V., Seghda, T. A. A., Kagambega, L. J., Diallo, O., Millogo, G. R. C., Toguyéni, B. J. Y., Samadoulougou, A. K., Niakara, A., Simporè, J., & Zabsonré, P. (2015) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2015.01.012 · Cited by 5
Anavekar, N. S., & Murphy, J. G. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.03.008 · Cited by 4
Self-citation
Metadata
- Authors
- Anavekar, N. S., Tleyjeh, I. M., Anavekar, N. S., Mirzoyev, Z., Steckelberg, J. M., Haddad, C., Khandaker, M. H., Wilson, W. R., Chandrasekaran, K., & Baddour, L. M.
- Affiliations
- King Fahd Medical City (SA)
- Mayo Clinic (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-05-01
- Volume
- 44
- Issue
- 9
- Pages
- 1180-1186
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2149023309
- Semantic Scholar
- eda90418fcdc68283dde09b5ba5c8a029226bcb1
- Cited by
- 138
- References
- 44
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 12 · 2019: 5 · 2018: 3 · 2017: 1 · 2016: 7 · 2015: 9 · 2014: 10 · 2013: 11 · 2012: 8
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
- Keywords
- infective endocarditis, embolism, antiplatelet therapy, aspirin, clopidogrel, ticlopidine, dipyridamole, stroke, platelet aggregation, embolic complications
- MeSH terms
- Clopidogrel, Aged, Aspirin, Dipyridamole, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Therapy, Combination, Embolism, Endocarditis, Bacterial, Female, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Retrospective Studies, Ticlopidine, Incidence, Prevalence, Risk Assessment, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.